Christopher Lowry
Concepts (648)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Serotonin | 60 | 2022 | 311 | 11.240 |
Why?
| Raphe Nuclei | 42 | 2019 | 118 | 10.350 |
Why?
| Tryptophan Hydroxylase | 34 | 2022 | 51 | 6.870 |
Why?
| Serotonergic Neurons | 16 | 2022 | 24 | 5.110 |
Why?
| Anxiety | 44 | 2021 | 888 | 5.060 |
Why?
| Mycobacterium | 12 | 2023 | 105 | 5.040 |
Why?
| Stress, Psychological | 36 | 2021 | 1021 | 4.870 |
Why?
| Mycobacteriaceae | 11 | 2023 | 21 | 4.670 |
Why?
| Dorsal Raphe Nucleus | 14 | 2023 | 27 | 3.920 |
Why?
| Neurons | 43 | 2022 | 1345 | 3.780 |
Why?
| Amygdala | 21 | 2022 | 180 | 3.740 |
Why?
| Proto-Oncogene Proteins c-fos | 23 | 2019 | 196 | 3.730 |
Why?
| Fear | 16 | 2023 | 313 | 3.680 |
Why?
| Corticotropin-Releasing Hormone | 18 | 2018 | 86 | 3.650 |
Why?
| Rats | 79 | 2022 | 5426 | 3.310 |
Why?
| Behavior, Animal | 24 | 2021 | 486 | 3.250 |
Why?
| Corticosterone | 24 | 2021 | 254 | 3.200 |
Why?
| Gastrointestinal Microbiome | 15 | 2023 | 561 | 3.050 |
Why?
| Microbiota | 14 | 2023 | 676 | 2.960 |
Why?
| Animals | 164 | 2023 | 34133 | 2.640 |
Why?
| Stress Disorders, Post-Traumatic | 14 | 2023 | 770 | 2.490 |
Why?
| Receptors, Corticotropin-Releasing Hormone | 9 | 2019 | 33 | 2.440 |
Why?
| Rats, Wistar | 34 | 2020 | 405 | 2.340 |
Why?
| Hyperthermia, Induced | 6 | 2023 | 67 | 2.240 |
Why?
| Anti-Inflammatory Agents | 9 | 2023 | 469 | 2.210 |
Why?
| Antidepressive Agents | 9 | 2023 | 194 | 2.140 |
Why?
| Inflammation | 26 | 2023 | 2598 | 2.110 |
Why?
| Extinction, Psychological | 4 | 2023 | 83 | 2.110 |
Why?
| Depressive Disorder, Major | 9 | 2023 | 309 | 2.080 |
Why?
| Central Nervous System | 10 | 2022 | 244 | 1.950 |
Why?
| Pituitary-Adrenal System | 11 | 2019 | 179 | 1.910 |
Why?
| Mental Health | 6 | 2023 | 571 | 1.880 |
Why?
| Hypothalamo-Hypophyseal System | 12 | 2019 | 215 | 1.880 |
Why?
| Serotonin Plasma Membrane Transport Proteins | 12 | 2022 | 75 | 1.870 |
Why?
| Anxiety Disorders | 11 | 2021 | 326 | 1.850 |
Why?
| Brain | 27 | 2022 | 2540 | 1.760 |
Why?
| Rats, Sprague-Dawley | 31 | 2022 | 2501 | 1.740 |
Why?
| Panic Disorder | 7 | 2017 | 23 | 1.690 |
Why?
| Organic Cation Transport Proteins | 9 | 2021 | 28 | 1.610 |
Why?
| Motor Activity | 12 | 2021 | 679 | 1.450 |
Why?
| Microglia | 6 | 2023 | 214 | 1.450 |
Why?
| Male | 125 | 2024 | 59639 | 1.440 |
Why?
| Bacterial Vaccines | 4 | 2018 | 61 | 1.390 |
Why?
| Glucocorticoids | 6 | 2023 | 554 | 1.380 |
Why?
| Fluoxetine | 6 | 2023 | 47 | 1.350 |
Why?
| Lipopolysaccharides | 6 | 2023 | 875 | 1.310 |
Why?
| Citalopram | 2 | 2018 | 28 | 1.280 |
Why?
| Hypothalamus | 6 | 2019 | 155 | 1.260 |
Why?
| Social Isolation | 3 | 2013 | 64 | 1.250 |
Why?
| Urocortins | 10 | 2019 | 21 | 1.240 |
Why?
| Analysis of Variance | 23 | 2018 | 1329 | 1.240 |
Why?
| Carbolines | 9 | 2015 | 29 | 1.230 |
Why?
| Probiotics | 2 | 2018 | 52 | 1.220 |
Why?
| Depressive Disorder | 3 | 2018 | 347 | 1.210 |
Why?
| Environment, Controlled | 3 | 2016 | 20 | 1.210 |
Why?
| Vaccines, Inactivated | 3 | 2018 | 68 | 1.210 |
Why?
| Body Temperature Regulation | 7 | 2019 | 73 | 1.210 |
Why?
| Salamandridae | 11 | 2009 | 26 | 1.170 |
Why?
| Neural Pathways | 12 | 2020 | 289 | 1.160 |
Why?
| Mood Disorders | 3 | 2013 | 122 | 1.130 |
Why?
| Depression | 11 | 2023 | 1190 | 1.120 |
Why?
| Dysbiosis | 2 | 2018 | 148 | 1.120 |
Why?
| Immunomodulation | 3 | 2016 | 91 | 1.110 |
Why?
| Disease Models, Animal | 19 | 2021 | 3799 | 1.090 |
Why?
| Cell Count | 14 | 2015 | 319 | 1.070 |
Why?
| Immunohistochemistry | 20 | 2019 | 1727 | 1.070 |
Why?
| Serotonin Receptor Agonists | 5 | 2017 | 28 | 1.070 |
Why?
| Hippocampus | 8 | 2022 | 747 | 1.030 |
Why?
| Panic | 4 | 2017 | 11 | 1.010 |
Why?
| RNA, Messenger | 9 | 2020 | 2720 | 0.990 |
Why?
| Tryptophan | 7 | 2018 | 140 | 0.980 |
Why?
| Dorsomedial Hypothalamic Nucleus | 3 | 2015 | 5 | 0.960 |
Why?
| Stress, Physiological | 11 | 2014 | 433 | 0.950 |
Why?
| Arousal | 6 | 2023 | 164 | 0.930 |
Why?
| Veterans | 7 | 2024 | 1203 | 0.920 |
Why?
| Receptor, Serotonin, 5-HT1A | 8 | 2019 | 39 | 0.910 |
Why?
| Septal Nuclei | 3 | 2019 | 17 | 0.910 |
Why?
| Maternal Deprivation | 4 | 2019 | 14 | 0.900 |
Why?
| Brain Injuries, Traumatic | 4 | 2020 | 325 | 0.880 |
Why?
| Caffeine | 5 | 2018 | 64 | 0.880 |
Why?
| Reflex, Startle | 4 | 2019 | 67 | 0.870 |
Why?
| Mental Disorders | 8 | 2022 | 952 | 0.860 |
Why?
| Inflammation Mediators | 3 | 2018 | 515 | 0.860 |
Why?
| Neurons, Afferent | 4 | 2012 | 92 | 0.850 |
Why?
| Anti-Anxiety Agents | 4 | 2015 | 41 | 0.840 |
Why?
| Social Behavior | 7 | 2022 | 291 | 0.840 |
Why?
| RNA, Ribosomal, 16S | 10 | 2022 | 535 | 0.840 |
Why?
| Hot Temperature | 3 | 2022 | 345 | 0.830 |
Why?
| Carbon Dioxide | 4 | 2010 | 237 | 0.830 |
Why?
| Prefrontal Cortex | 3 | 2018 | 280 | 0.830 |
Why?
| Cytomegalovirus Infections | 1 | 2023 | 188 | 0.820 |
Why?
| Hydroxyindoleacetic Acid | 11 | 2018 | 18 | 0.820 |
Why?
| Immunization | 9 | 2022 | 421 | 0.810 |
Why?
| Feces | 5 | 2023 | 410 | 0.810 |
Why?
| Veterans Health | 2 | 2024 | 167 | 0.800 |
Why?
| Colitis | 4 | 2019 | 227 | 0.770 |
Why?
| Cerebrospinal Fluid Proteins | 1 | 2020 | 9 | 0.740 |
Why?
| Exploratory Behavior | 5 | 2021 | 93 | 0.730 |
Why?
| Mice, Inbred BALB C | 12 | 2023 | 1245 | 0.730 |
Why?
| Environment Design | 2 | 2016 | 22 | 0.710 |
Why?
| Toxoplasmosis | 4 | 2024 | 31 | 0.710 |
Why?
| Mice | 31 | 2023 | 15888 | 0.690 |
Why?
| Body Temperature | 4 | 2018 | 219 | 0.690 |
Why?
| Locomotion | 6 | 2021 | 84 | 0.690 |
Why?
| Emotions | 5 | 2023 | 524 | 0.690 |
Why?
| Synaptic Transmission | 4 | 2018 | 240 | 0.680 |
Why?
| Serotonin Agents | 4 | 2015 | 9 | 0.680 |
Why?
| Interleukin-4 | 1 | 2020 | 230 | 0.680 |
Why?
| Humans | 82 | 2024 | 122796 | 0.670 |
Why?
| Dominance-Subordination | 2 | 2011 | 16 | 0.670 |
Why?
| Genes, fos | 2 | 2010 | 36 | 0.640 |
Why?
| Catecholamines | 3 | 2005 | 103 | 0.630 |
Why?
| Physical Conditioning, Animal | 2 | 2019 | 206 | 0.630 |
Why?
| Housing, Animal | 2 | 2016 | 49 | 0.630 |
Why?
| Blood Proteins | 1 | 2020 | 249 | 0.620 |
Why?
| Behavior | 1 | 2018 | 99 | 0.620 |
Why?
| Swimming | 3 | 2021 | 47 | 0.620 |
Why?
| 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2017 | 10 | 0.610 |
Why?
| Hypothermia | 1 | 2017 | 34 | 0.610 |
Why?
| Gastrointestinal Tract | 1 | 2019 | 176 | 0.600 |
Why?
| Gene Expression Regulation | 9 | 2018 | 2491 | 0.600 |
Why?
| Circadian Rhythm | 4 | 2021 | 414 | 0.590 |
Why?
| Hypercapnia | 4 | 2012 | 53 | 0.590 |
Why?
| Vaccination | 3 | 2020 | 1241 | 0.590 |
Why?
| Psychological Trauma | 1 | 2017 | 55 | 0.580 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2013 | 852 | 0.580 |
Why?
| Military Personnel | 3 | 2019 | 584 | 0.580 |
Why?
| Toxoplasma | 3 | 2024 | 34 | 0.570 |
Why?
| Lipid Metabolism | 1 | 2020 | 482 | 0.570 |
Why?
| Social Determinants of Health | 1 | 2018 | 141 | 0.570 |
Why?
| Parvalbumins | 2 | 2020 | 19 | 0.570 |
Why?
| Brain Concussion | 2 | 2020 | 470 | 0.560 |
Why?
| Immune System | 2 | 2014 | 184 | 0.550 |
Why?
| Organic Anion Transporters, Sodium-Independent | 2 | 2019 | 4 | 0.520 |
Why?
| Vasotocin | 4 | 2000 | 5 | 0.520 |
Why?
| Post-Concussion Syndrome | 1 | 2017 | 137 | 0.500 |
Why?
| Gene Expression | 7 | 2020 | 1506 | 0.490 |
Why?
| Hormone Replacement Therapy | 1 | 2015 | 80 | 0.490 |
Why?
| Conditioning, Classical | 5 | 2020 | 90 | 0.480 |
Why?
| Immobility Response, Tonic | 1 | 2013 | 4 | 0.480 |
Why?
| Proteomics | 1 | 2020 | 890 | 0.480 |
Why?
| Cytokines | 7 | 2023 | 1928 | 0.470 |
Why?
| Intestines | 2 | 2014 | 338 | 0.460 |
Why?
| Interleukin-6 | 4 | 2023 | 702 | 0.460 |
Why?
| Mesencephalon | 2 | 2010 | 57 | 0.450 |
Why?
| Pons | 2 | 2010 | 31 | 0.450 |
Why?
| Adaptation, Psychological | 3 | 2014 | 569 | 0.450 |
Why?
| T-Lymphocytes, Regulatory | 3 | 2016 | 367 | 0.450 |
Why?
| Sex Characteristics | 2 | 2013 | 690 | 0.450 |
Why?
| Cold Temperature | 1 | 2013 | 136 | 0.440 |
Why?
| Life Style | 2 | 2014 | 436 | 0.440 |
Why?
| GABA Antagonists | 6 | 2013 | 33 | 0.440 |
Why?
| Mice, Inbred C57BL | 12 | 2022 | 5020 | 0.430 |
Why?
| GABAergic Neurons | 1 | 2012 | 21 | 0.420 |
Why?
| Prosencephalon | 6 | 2018 | 50 | 0.420 |
Why?
| gamma-Aminobutyric Acid | 3 | 2017 | 155 | 0.420 |
Why?
| Cushing Syndrome | 1 | 2011 | 10 | 0.420 |
Why?
| Kynurenine | 5 | 2018 | 81 | 0.410 |
Why?
| Public Health | 1 | 2016 | 480 | 0.410 |
Why?
| Time Factors | 12 | 2015 | 6682 | 0.410 |
Why?
| Rats, Long-Evans | 6 | 2021 | 104 | 0.400 |
Why?
| Dose-Response Relationship, Drug | 12 | 2015 | 1981 | 0.390 |
Why?
| Suicide | 4 | 2020 | 498 | 0.390 |
Why?
| Socioeconomic Factors | 2 | 2014 | 1158 | 0.390 |
Why?
| Bronchi | 1 | 2012 | 253 | 0.380 |
Why?
| Brain Mapping | 5 | 2007 | 552 | 0.380 |
Why?
| Breast Neoplasms | 1 | 2022 | 1994 | 0.380 |
Why?
| Third Ventricle | 1 | 2010 | 14 | 0.380 |
Why?
| Light | 3 | 2008 | 346 | 0.370 |
Why?
| NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2023 | 152 | 0.370 |
Why?
| Suicide, Attempted | 3 | 2019 | 331 | 0.360 |
Why?
| Animals, Newborn | 5 | 2018 | 825 | 0.360 |
Why?
| Interneurons | 1 | 2010 | 103 | 0.350 |
Why?
| Fenfluramine | 1 | 2009 | 13 | 0.350 |
Why?
| Prebiotics | 2 | 2021 | 25 | 0.350 |
Why?
| Female | 33 | 2024 | 63629 | 0.340 |
Why?
| Cognition | 4 | 2022 | 1066 | 0.340 |
Why?
| Amish | 2 | 2019 | 8 | 0.330 |
Why?
| TRPV Cation Channels | 1 | 2008 | 35 | 0.330 |
Why?
| Pets | 2 | 2018 | 21 | 0.330 |
Why?
| Brain Chemistry | 4 | 2007 | 120 | 0.330 |
Why?
| Medulla Oblongata | 4 | 2012 | 33 | 0.330 |
Why?
| Chromatography, High Pressure Liquid | 7 | 2018 | 493 | 0.330 |
Why?
| Sexual Behavior, Animal | 4 | 2006 | 52 | 0.320 |
Why?
| RNA, Bacterial | 2 | 2020 | 180 | 0.310 |
Why?
| Periaqueductal Gray | 3 | 2017 | 15 | 0.310 |
Why?
| Encephalitis | 2 | 2020 | 128 | 0.300 |
Why?
| Sleep Deprivation | 2 | 2020 | 174 | 0.300 |
Why?
| T-Lymphocytes, Helper-Inducer | 1 | 2008 | 133 | 0.300 |
Why?
| Relaxin | 2 | 2018 | 15 | 0.300 |
Why?
| Proto-Oncogene Proteins c-fyn | 1 | 2007 | 19 | 0.300 |
Why?
| Allosteric Site | 1 | 2007 | 17 | 0.300 |
Why?
| Neuropeptides | 3 | 2018 | 70 | 0.300 |
Why?
| Age Factors | 7 | 2021 | 3114 | 0.300 |
Why?
| Limbic System | 1 | 2007 | 42 | 0.300 |
Why?
| Rats, Inbred F344 | 4 | 2019 | 245 | 0.300 |
Why?
| Vaccines | 1 | 2012 | 384 | 0.290 |
Why?
| Schizophrenia | 3 | 2016 | 544 | 0.290 |
Why?
| Maze Learning | 6 | 2021 | 87 | 0.290 |
Why?
| Histamine | 2 | 2006 | 64 | 0.280 |
Why?
| Restraint, Physical | 4 | 2015 | 94 | 0.280 |
Why?
| Receptors, GABA-A | 1 | 2007 | 88 | 0.280 |
Why?
| Indomethacin | 1 | 2006 | 76 | 0.280 |
Why?
| 5-Hydroxytryptophan | 5 | 2022 | 22 | 0.280 |
Why?
| Aging | 4 | 2022 | 1694 | 0.280 |
Why?
| Cyclooxygenase Inhibitors | 1 | 2006 | 72 | 0.280 |
Why?
| Benzodiazepines | 1 | 2007 | 125 | 0.280 |
Why?
| Telemetry | 2 | 2017 | 33 | 0.270 |
Why?
| Receptors, Serotonin, 5-HT3 | 1 | 2005 | 17 | 0.270 |
Why?
| Biguanides | 1 | 2005 | 14 | 0.270 |
Why?
| Up-Regulation | 4 | 2012 | 891 | 0.270 |
Why?
| Hypothalamic Area, Lateral | 1 | 2005 | 3 | 0.270 |
Why?
| Prolactin | 2 | 2005 | 97 | 0.270 |
Why?
| In Situ Hybridization | 5 | 2012 | 324 | 0.270 |
Why?
| Antibodies, Protozoan | 3 | 2024 | 28 | 0.270 |
Why?
| Environmental Microbiology | 2 | 2019 | 44 | 0.260 |
Why?
| Bacteria | 3 | 2020 | 772 | 0.260 |
Why?
| Vimentin | 1 | 2005 | 62 | 0.260 |
Why?
| Adrenal Medulla | 1 | 2004 | 7 | 0.250 |
Why?
| Life Change Events | 1 | 2005 | 138 | 0.250 |
Why?
| Fibroblast Growth Factor 8 | 2 | 2014 | 27 | 0.240 |
Why?
| Dopamine | 3 | 2018 | 250 | 0.240 |
Why?
| Adjuvants, Pharmaceutic | 1 | 2023 | 12 | 0.240 |
Why?
| Macrophages | 2 | 2023 | 1334 | 0.240 |
Why?
| Helicobacter Infections | 2 | 2021 | 25 | 0.240 |
Why?
| Neuroimmunomodulation | 2 | 2019 | 72 | 0.240 |
Why?
| Tuberculosis, Bovine | 1 | 2023 | 3 | 0.240 |
Why?
| Paraventricular Hypothalamic Nucleus | 2 | 2018 | 36 | 0.230 |
Why?
| Cerebral Cortex | 1 | 2007 | 430 | 0.230 |
Why?
| Suicidal Ideation | 2 | 2019 | 413 | 0.230 |
Why?
| Friends | 1 | 2023 | 48 | 0.220 |
Why?
| Receptors, Neuropeptide | 2 | 2012 | 11 | 0.220 |
Why?
| Mucins | 1 | 2022 | 64 | 0.220 |
Why?
| Adjuvants, Immunologic | 1 | 2023 | 211 | 0.220 |
Why?
| Random Allocation | 4 | 2009 | 360 | 0.210 |
Why?
| Coinfection | 1 | 2023 | 122 | 0.210 |
Why?
| Planets | 1 | 2021 | 1 | 0.210 |
Why?
| Hydrazines | 3 | 2018 | 32 | 0.210 |
Why?
| Norepinephrine | 5 | 2005 | 214 | 0.210 |
Why?
| Serotonin Antagonists | 2 | 2015 | 31 | 0.210 |
Why?
| Helicobacter pylori | 1 | 2021 | 32 | 0.200 |
Why?
| Populus | 1 | 2021 | 10 | 0.200 |
Why?
| Frailty | 1 | 2024 | 117 | 0.200 |
Why?
| Adult | 17 | 2020 | 32385 | 0.200 |
Why?
| Hygiene | 2 | 2014 | 35 | 0.200 |
Why?
| Piperazines | 3 | 2010 | 326 | 0.200 |
Why?
| Diet, High-Fat | 2 | 2022 | 248 | 0.200 |
Why?
| Cholera Toxin | 3 | 2013 | 28 | 0.200 |
Why?
| Adrenalectomy | 2 | 2015 | 79 | 0.200 |
Why?
| Groundwater | 1 | 2021 | 32 | 0.190 |
Why?
| Brain Stem | 3 | 2006 | 104 | 0.190 |
Why?
| Microdialysis | 5 | 2019 | 65 | 0.190 |
Why?
| Temporomandibular Joint | 1 | 2020 | 12 | 0.190 |
Why?
| Escape Reaction | 2 | 2017 | 68 | 0.190 |
Why?
| Carrier Proteins | 1 | 2005 | 740 | 0.190 |
Why?
| Epinephrine | 2 | 2005 | 166 | 0.190 |
Why?
| Multiple Trauma | 1 | 2021 | 98 | 0.190 |
Why?
| Receptors, G-Protein-Coupled | 2 | 2012 | 207 | 0.190 |
Why?
| Porphyromonas gingivalis | 1 | 2020 | 15 | 0.180 |
Why?
| Bile Acids and Salts | 1 | 2021 | 182 | 0.180 |
Why?
| Gain of Function Mutation | 1 | 2020 | 32 | 0.180 |
Why?
| In Vitro Techniques | 3 | 2009 | 1130 | 0.180 |
Why?
| Seasonal Affective Disorder | 1 | 2020 | 9 | 0.180 |
Why?
| Neuropsychiatry | 1 | 2020 | 15 | 0.180 |
Why?
| Mycobacterium tuberculosis | 1 | 2023 | 304 | 0.180 |
Why?
| Immunoglobulin G | 3 | 2024 | 804 | 0.180 |
Why?
| DNA, Bacterial | 2 | 2020 | 324 | 0.180 |
Why?
| Mice, Inbred Strains | 1 | 2020 | 418 | 0.180 |
Why?
| Autoradiography | 2 | 2009 | 73 | 0.180 |
Why?
| Receptors, Calcitriol | 1 | 2020 | 57 | 0.180 |
Why?
| Shock | 1 | 2021 | 96 | 0.180 |
Why?
| Periodontitis | 1 | 2020 | 42 | 0.180 |
Why?
| United States | 6 | 2024 | 13272 | 0.180 |
Why?
| United States Department of Veterans Affairs | 2 | 2024 | 564 | 0.180 |
Why?
| Central Amygdaloid Nucleus | 1 | 2019 | 4 | 0.170 |
Why?
| Psycholinguistics | 1 | 2019 | 18 | 0.170 |
Why?
| Individuality | 2 | 2019 | 152 | 0.170 |
Why?
| Mice, 129 Strain | 1 | 2019 | 80 | 0.170 |
Why?
| Phobic Disorders | 1 | 2019 | 29 | 0.170 |
Why?
| Sleep Disorders, Circadian Rhythm | 1 | 2019 | 46 | 0.170 |
Why?
| Middle Aged | 10 | 2020 | 28563 | 0.170 |
Why?
| Memory, Episodic | 1 | 2019 | 44 | 0.170 |
Why?
| Animal Assisted Therapy | 1 | 2018 | 8 | 0.170 |
Why?
| Hypothalamus, Middle | 2 | 2010 | 2 | 0.160 |
Why?
| Mice, Knockout | 4 | 2019 | 2737 | 0.160 |
Why?
| Alarmins | 1 | 2018 | 25 | 0.160 |
Why?
| Mycobacterium Infections, Nontuberculous | 1 | 2023 | 334 | 0.160 |
Why?
| Yohimbine | 2 | 2010 | 9 | 0.160 |
Why?
| Nervous System | 1 | 1998 | 67 | 0.160 |
Why?
| Autism Spectrum Disorder | 2 | 2020 | 350 | 0.160 |
Why?
| Biogenic Monoamines | 2 | 2009 | 14 | 0.160 |
Why?
| Nesting Behavior | 1 | 2018 | 18 | 0.160 |
Why?
| HMGB1 Protein | 1 | 2018 | 48 | 0.160 |
Why?
| Housing | 1 | 2019 | 125 | 0.160 |
Why?
| Adiponectin | 1 | 2020 | 231 | 0.160 |
Why?
| Grooming | 2 | 2009 | 8 | 0.160 |
Why?
| Vasopressins | 1 | 1998 | 64 | 0.160 |
Why?
| Injections, Intraventricular | 2 | 2009 | 74 | 0.160 |
Why?
| Trauma and Stressor Related Disorders | 1 | 2017 | 2 | 0.160 |
Why?
| Biomarkers | 3 | 2024 | 3662 | 0.160 |
Why?
| Vertebrates | 1 | 1998 | 65 | 0.160 |
Why?
| Phenylalanine | 1 | 2018 | 69 | 0.160 |
Why?
| MicroRNAs | 2 | 2014 | 661 | 0.160 |
Why?
| Amphibians | 1 | 1998 | 50 | 0.160 |
Why?
| Desipramine | 2 | 2015 | 9 | 0.150 |
Why?
| Food Chain | 1 | 2017 | 39 | 0.150 |
Why?
| Receptors, Glucocorticoid | 2 | 2017 | 136 | 0.150 |
Why?
| Neopterin | 1 | 2017 | 9 | 0.150 |
Why?
| Genetic Fitness | 1 | 2018 | 58 | 0.150 |
Why?
| Noise | 1 | 2018 | 72 | 0.150 |
Why?
| Songbirds | 1 | 2018 | 38 | 0.150 |
Why?
| Helicobacter | 1 | 2016 | 4 | 0.150 |
Why?
| Tyrosine | 1 | 2018 | 267 | 0.150 |
Why?
| Altitude | 1 | 2021 | 425 | 0.150 |
Why?
| Impulsive Behavior | 1 | 2018 | 122 | 0.150 |
Why?
| Gliadin | 1 | 2016 | 12 | 0.150 |
Why?
| Soil Microbiology | 1 | 2019 | 183 | 0.150 |
Why?
| Sequence Analysis, DNA | 1 | 2020 | 766 | 0.150 |
Why?
| Lipids | 1 | 2020 | 614 | 0.140 |
Why?
| Psychomotor Performance | 1 | 2019 | 307 | 0.140 |
Why?
| Tissue Distribution | 3 | 2006 | 339 | 0.140 |
Why?
| Video Recording | 2 | 2009 | 167 | 0.140 |
Why?
| Hydrocortisone | 2 | 2018 | 315 | 0.140 |
Why?
| Nerve Tissue Proteins | 2 | 2018 | 557 | 0.140 |
Why?
| Drug Administration Routes | 2 | 2007 | 44 | 0.140 |
Why?
| Biogenic Amines | 1 | 1996 | 4 | 0.140 |
Why?
| Immunity, Cellular | 1 | 2018 | 276 | 0.140 |
Why?
| Sick Building Syndrome | 1 | 2015 | 4 | 0.140 |
Why?
| Rectum | 1 | 2017 | 158 | 0.140 |
Why?
| Epilepsy | 1 | 2020 | 291 | 0.140 |
Why?
| Affect | 1 | 2018 | 254 | 0.140 |
Why?
| Down-Regulation | 1 | 2018 | 654 | 0.140 |
Why?
| Adrenal Glands | 2 | 2016 | 75 | 0.140 |
Why?
| Combined Modality Therapy | 1 | 2018 | 1174 | 0.130 |
Why?
| Leukocytes, Mononuclear | 1 | 2018 | 514 | 0.130 |
Why?
| Urban Population | 1 | 2018 | 425 | 0.130 |
Why?
| Radioimmunoassay | 2 | 2009 | 168 | 0.130 |
Why?
| Cross-Sectional Studies | 2 | 2024 | 4734 | 0.130 |
Why?
| Membrane Potentials | 1 | 1996 | 273 | 0.130 |
Why?
| Staining and Labeling | 2 | 2006 | 159 | 0.130 |
Why?
| Argonaute Proteins | 1 | 2014 | 30 | 0.130 |
Why?
| Learning | 1 | 2019 | 387 | 0.130 |
Why?
| Feedback, Physiological | 1 | 2015 | 78 | 0.130 |
Why?
| Receptors, Steroid | 1 | 1995 | 54 | 0.130 |
Why?
| Hypoxia | 1 | 2021 | 1003 | 0.130 |
Why?
| Receptors, Adrenergic, beta-1 | 1 | 2014 | 53 | 0.120 |
Why?
| Metabolic Networks and Pathways | 1 | 2015 | 178 | 0.120 |
Why?
| Extracellular Space | 2 | 2019 | 132 | 0.120 |
Why?
| Urbanization | 1 | 2014 | 25 | 0.120 |
Why?
| Sleep | 4 | 2021 | 722 | 0.120 |
Why?
| Rural Population | 1 | 2018 | 482 | 0.120 |
Why?
| Chronic Disease | 2 | 2019 | 1645 | 0.120 |
Why?
| White Matter | 1 | 2016 | 119 | 0.120 |
Why?
| Alzheimer Disease | 1 | 2020 | 513 | 0.120 |
Why?
| Oncogene Proteins v-fos | 1 | 2013 | 13 | 0.120 |
Why?
| Cognitive Dysfunction | 1 | 2018 | 309 | 0.120 |
Why?
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2014 | 53 | 0.120 |
Why?
| Proteins | 1 | 2020 | 953 | 0.120 |
Why?
| Antidepressive Agents, Tricyclic | 1 | 2013 | 32 | 0.120 |
Why?
| Emigration and Immigration | 1 | 2014 | 52 | 0.120 |
Why?
| Respiration Disorders | 1 | 2014 | 67 | 0.120 |
Why?
| Receptors, Opioid | 2 | 1990 | 19 | 0.120 |
Why?
| Bradycardia | 2 | 2012 | 58 | 0.120 |
Why?
| Receptors, Angiotensin | 1 | 2013 | 10 | 0.120 |
Why?
| Biological Evolution | 2 | 2014 | 457 | 0.110 |
Why?
| Comorbidity | 2 | 2017 | 1600 | 0.110 |
Why?
| Deoxyadenine Nucleotides | 1 | 2013 | 13 | 0.110 |
Why?
| Rodentia | 1 | 2013 | 48 | 0.110 |
Why?
| Skin | 3 | 2023 | 694 | 0.110 |
Why?
| Follow-Up Studies | 3 | 2018 | 4768 | 0.110 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 839 | 0.110 |
Why?
| Weight Gain | 2 | 2019 | 511 | 0.110 |
Why?
| Amphetamine | 1 | 2012 | 23 | 0.110 |
Why?
| Adrenocorticotropic Hormone | 2 | 2011 | 153 | 0.110 |
Why?
| Avoidance Learning | 1 | 2013 | 66 | 0.110 |
Why?
| Resilience, Psychological | 1 | 2014 | 101 | 0.110 |
Why?
| Serotonin 5-HT1 Receptor Agonists | 1 | 2012 | 3 | 0.110 |
Why?
| Sodium Lactate | 2 | 2013 | 5 | 0.110 |
Why?
| Angiotensin II | 1 | 2013 | 108 | 0.110 |
Why?
| Pilot Projects | 1 | 2017 | 1477 | 0.110 |
Why?
| Body Weight | 1 | 2017 | 958 | 0.110 |
Why?
| Young Adult | 5 | 2019 | 11094 | 0.110 |
Why?
| Weaning | 1 | 2012 | 59 | 0.110 |
Why?
| Brain Injuries | 1 | 2017 | 488 | 0.100 |
Why?
| Phenotype | 3 | 2021 | 3070 | 0.100 |
Why?
| Homeostasis | 1 | 2015 | 596 | 0.100 |
Why?
| Memory | 3 | 2018 | 242 | 0.100 |
Why?
| Cohort Studies | 2 | 2019 | 5294 | 0.100 |
Why?
| Quality of Life | 1 | 2022 | 2457 | 0.100 |
Why?
| Electroshock | 3 | 2017 | 150 | 0.100 |
Why?
| Cell Line, Transformed | 1 | 2011 | 140 | 0.100 |
Why?
| Hypertension | 2 | 2012 | 1245 | 0.100 |
Why?
| Neuronal Tract-Tracers | 1 | 2010 | 2 | 0.090 |
Why?
| Sanitation | 1 | 2010 | 55 | 0.090 |
Why?
| Receptor, Serotonin, 5-HT2A | 1 | 2010 | 19 | 0.090 |
Why?
| Receptors, Adrenergic | 2 | 2006 | 36 | 0.090 |
Why?
| Substance Withdrawal Syndrome | 1 | 2012 | 159 | 0.090 |
Why?
| Gene-Environment Interaction | 1 | 2012 | 206 | 0.090 |
Why?
| Injections, Intraperitoneal | 2 | 2009 | 107 | 0.090 |
Why?
| Cell Lineage | 1 | 2012 | 326 | 0.090 |
Why?
| Environmental Exposure | 1 | 2014 | 427 | 0.090 |
Why?
| Signal Transduction | 2 | 2015 | 4902 | 0.090 |
Why?
| Radiography | 1 | 2013 | 888 | 0.090 |
Why?
| Catheters, Indwelling | 1 | 2010 | 82 | 0.090 |
Why?
| Diet | 3 | 2023 | 1168 | 0.090 |
Why?
| Social Dominance | 1 | 2009 | 18 | 0.090 |
Why?
| Tyrosine 3-Monooxygenase | 2 | 2007 | 70 | 0.090 |
Why?
| Aromatic Amino Acid Decarboxylase Inhibitors | 1 | 2009 | 1 | 0.090 |
Why?
| Feeding Behavior | 2 | 2006 | 627 | 0.090 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 432 | 0.090 |
Why?
| Species Specificity | 2 | 2018 | 578 | 0.090 |
Why?
| Green Fluorescent Proteins | 1 | 2011 | 402 | 0.090 |
Why?
| Thermosensing | 1 | 2008 | 10 | 0.090 |
Why?
| Pyridines | 2 | 2013 | 440 | 0.080 |
Why?
| Pargyline | 1 | 2008 | 2 | 0.080 |
Why?
| Transfection | 1 | 2011 | 909 | 0.080 |
Why?
| Temperature | 1 | 2011 | 631 | 0.080 |
Why?
| Biological Transport | 2 | 2006 | 392 | 0.080 |
Why?
| Neuropsychological Tests | 2 | 2020 | 1072 | 0.080 |
Why?
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2008 | 12 | 0.080 |
Why?
| Seroepidemiologic Studies | 2 | 2019 | 147 | 0.080 |
Why?
| Immune Tolerance | 1 | 2010 | 355 | 0.080 |
Why?
| Central Nervous System Stimulants | 2 | 2012 | 143 | 0.080 |
Why?
| T-Lymphocyte Subsets | 1 | 2010 | 409 | 0.080 |
Why?
| Mice, Transgenic | 4 | 2014 | 2079 | 0.080 |
Why?
| Somatoform Disorders | 1 | 2007 | 41 | 0.080 |
Why?
| Acoustic Stimulation | 1 | 2009 | 333 | 0.080 |
Why?
| Seasons | 2 | 2020 | 468 | 0.080 |
Why?
| Synapses | 1 | 2010 | 347 | 0.080 |
Why?
| Bronchopulmonary Sequestration | 1 | 2007 | 9 | 0.080 |
Why?
| Statistics as Topic | 1 | 2008 | 314 | 0.080 |
Why?
| Tryptamines | 1 | 2006 | 4 | 0.070 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2007 | 131 | 0.070 |
Why?
| Darkness | 1 | 2006 | 21 | 0.070 |
Why?
| Amino Acid Sequence | 1 | 2011 | 2123 | 0.070 |
Why?
| Aged | 3 | 2024 | 20495 | 0.070 |
Why?
| Tegmentum Mesencephali | 1 | 2006 | 4 | 0.070 |
Why?
| Evidence-Based Medicine | 1 | 2010 | 731 | 0.070 |
Why?
| Tissue Fixation | 1 | 2005 | 33 | 0.070 |
Why?
| Blood-Brain Barrier | 1 | 2006 | 107 | 0.070 |
Why?
| Chromatography, Liquid | 2 | 2021 | 356 | 0.070 |
Why?
| Drug Interactions | 1 | 2007 | 356 | 0.070 |
Why?
| Median Eminence | 1 | 2005 | 5 | 0.070 |
Why?
| Arcuate Nucleus of Hypothalamus | 1 | 2005 | 14 | 0.070 |
Why?
| Cell Membrane | 2 | 2022 | 741 | 0.070 |
Why?
| Stilbamidines | 1 | 2005 | 10 | 0.070 |
Why?
| Peptide Fragments | 2 | 2008 | 715 | 0.070 |
Why?
| Adrenergic alpha-Antagonists | 1 | 2005 | 31 | 0.060 |
Why?
| Injections | 1 | 2005 | 171 | 0.060 |
Why?
| Heart Atria | 1 | 2005 | 121 | 0.060 |
Why?
| Image Processing, Computer-Assisted | 1 | 2009 | 739 | 0.060 |
Why?
| Perfusion | 1 | 2005 | 160 | 0.060 |
Why?
| Blood Pressure | 2 | 2013 | 1713 | 0.060 |
Why?
| Microinjections | 2 | 2015 | 85 | 0.060 |
Why?
| Neurons, Efferent | 1 | 2004 | 7 | 0.060 |
Why?
| Genes, Immediate-Early | 1 | 2004 | 18 | 0.060 |
Why?
| Nerve Fibers | 1 | 2005 | 88 | 0.060 |
Why?
| Autoimmunity | 1 | 2010 | 852 | 0.060 |
Why?
| Lomustine | 1 | 2024 | 14 | 0.060 |
Why?
| Sympathetic Nervous System | 1 | 2005 | 173 | 0.060 |
Why?
| Genotype | 2 | 2020 | 1943 | 0.060 |
Why?
| Action Potentials | 2 | 2011 | 433 | 0.060 |
Why?
| Prednisone | 1 | 2024 | 234 | 0.060 |
Why?
| Rats, Inbred Lew | 1 | 2003 | 87 | 0.060 |
Why?
| Blood Glucose | 2 | 2011 | 1957 | 0.060 |
Why?
| Carbidopa | 1 | 2022 | 3 | 0.050 |
Why?
| Orexin Receptors | 2 | 2012 | 4 | 0.050 |
Why?
| Immunoglobulin M | 1 | 2024 | 288 | 0.050 |
Why?
| Psychiatric Status Rating Scales | 2 | 2016 | 531 | 0.050 |
Why?
| Psychoneuroimmunology | 1 | 2022 | 12 | 0.050 |
Why?
| Fathers | 1 | 2022 | 47 | 0.050 |
Why?
| Receptors, Interleukin-6 | 1 | 2022 | 36 | 0.050 |
Why?
| Polysomnography | 2 | 2019 | 177 | 0.050 |
Why?
| Blotting, Western | 1 | 2005 | 1225 | 0.050 |
Why?
| Bacteroidetes | 1 | 2021 | 22 | 0.050 |
Why?
| Exercise | 1 | 2012 | 1743 | 0.050 |
Why?
| Models, Biological | 2 | 2007 | 1756 | 0.050 |
Why?
| Anhedonia | 1 | 2021 | 10 | 0.050 |
Why?
| Supervised Machine Learning | 1 | 2021 | 12 | 0.050 |
Why?
| Endophenotypes | 1 | 2021 | 31 | 0.050 |
Why?
| Granulocytes | 1 | 2021 | 79 | 0.050 |
Why?
| Biodegradation, Environmental | 1 | 2021 | 82 | 0.050 |
Why?
| Microfilament Proteins | 1 | 2022 | 135 | 0.050 |
Why?
| Nontuberculous Mycobacteria | 1 | 2023 | 205 | 0.050 |
Why?
| Dreams | 1 | 2000 | 13 | 0.050 |
Why?
| Rivers | 1 | 2021 | 61 | 0.050 |
Why?
| Trees | 1 | 2021 | 73 | 0.050 |
Why?
| Dietary Sucrose | 1 | 2021 | 55 | 0.050 |
Why?
| Microelectrodes | 1 | 2000 | 33 | 0.050 |
Why?
| Cations | 1 | 2021 | 80 | 0.050 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2021 | 242 | 0.050 |
Why?
| Calcium-Binding Proteins | 1 | 2022 | 222 | 0.050 |
Why?
| Choice Behavior | 1 | 2022 | 171 | 0.050 |
Why?
| Cattle | 1 | 2023 | 994 | 0.050 |
Why?
| Benzomorphans | 2 | 1990 | 2 | 0.050 |
Why?
| Positive-Pressure Respiration | 1 | 2000 | 78 | 0.050 |
Why?
| Cathelicidins | 1 | 2020 | 39 | 0.050 |
Why?
| DNA, Ribosomal | 1 | 2020 | 82 | 0.050 |
Why?
| Toll-Like Receptor 4 | 1 | 2023 | 335 | 0.050 |
Why?
| Metagenomics | 1 | 2021 | 144 | 0.050 |
Why?
| Sleep Apnea Syndromes | 1 | 2000 | 88 | 0.040 |
Why?
| Antimicrobial Cationic Peptides | 1 | 2020 | 77 | 0.040 |
Why?
| Normetanephrine | 1 | 2019 | 2 | 0.040 |
Why?
| ROC Curve | 1 | 2021 | 494 | 0.040 |
Why?
| Patient Care Team | 1 | 2024 | 520 | 0.040 |
Why?
| Chromosome Mapping | 1 | 2020 | 518 | 0.040 |
Why?
| Lymphocytes | 1 | 2021 | 360 | 0.040 |
Why?
| Administration, Intranasal | 1 | 2019 | 74 | 0.040 |
Why?
| Dextran Sulfate | 1 | 2019 | 71 | 0.040 |
Why?
| Asthma | 1 | 2012 | 2130 | 0.040 |
Why?
| Photic Stimulation | 1 | 2020 | 215 | 0.040 |
Why?
| Electroencephalography | 1 | 2021 | 408 | 0.040 |
Why?
| Axons | 1 | 2000 | 185 | 0.040 |
Why?
| Interpersonal Relations | 2 | 2015 | 351 | 0.040 |
Why?
| Tandem Mass Spectrometry | 1 | 2021 | 423 | 0.040 |
Why?
| Reaction Time | 1 | 2000 | 416 | 0.040 |
Why?
| Social Environment | 2 | 2010 | 301 | 0.040 |
Why?
| Optogenetics | 1 | 2020 | 96 | 0.040 |
Why?
| Patient-Centered Care | 1 | 2024 | 513 | 0.040 |
Why?
| Wakefulness | 1 | 2019 | 141 | 0.040 |
Why?
| Quantitative Trait Loci | 1 | 2020 | 328 | 0.040 |
Why?
| Metabolome | 1 | 2021 | 299 | 0.040 |
Why?
| Task Performance and Analysis | 1 | 2019 | 170 | 0.040 |
Why?
| Serologic Tests | 1 | 2018 | 56 | 0.040 |
Why?
| Extracellular Fluid | 2 | 2010 | 32 | 0.040 |
Why?
| Germany | 1 | 2018 | 90 | 0.040 |
Why?
| Agoraphobia | 1 | 2017 | 6 | 0.040 |
Why?
| Feathers | 1 | 2018 | 36 | 0.040 |
Why?
| Patient Reported Outcome Measures | 1 | 2020 | 258 | 0.040 |
Why?
| Nucleic Acid Probes | 1 | 1997 | 1 | 0.040 |
Why?
| Ethylmaleimide | 1 | 1997 | 18 | 0.040 |
Why?
| Thionucleotides | 1 | 1997 | 34 | 0.040 |
Why?
| Inhibitory Postsynaptic Potentials | 1 | 2017 | 32 | 0.040 |
Why?
| Dogs | 1 | 2018 | 382 | 0.040 |
Why?
| Body Size | 1 | 2018 | 95 | 0.040 |
Why?
| Picrotoxin | 1 | 2017 | 14 | 0.040 |
Why?
| Healthy Volunteers | 1 | 2018 | 209 | 0.040 |
Why?
| Oxytocin | 1 | 1997 | 46 | 0.040 |
Why?
| Biodiversity | 1 | 2021 | 386 | 0.040 |
Why?
| Pregnancy | 3 | 2020 | 5854 | 0.040 |
Why?
| Quinolines | 2 | 2010 | 127 | 0.040 |
Why?
| Risk Factors | 2 | 2024 | 9381 | 0.040 |
Why?
| Nerve Net | 1 | 2020 | 249 | 0.040 |
Why?
| Arizona | 1 | 2016 | 70 | 0.040 |
Why?
| Anisotropy | 1 | 2016 | 69 | 0.040 |
Why?
| Computational Biology | 1 | 2020 | 601 | 0.040 |
Why?
| 5,7-Dihydroxytryptamine | 1 | 2015 | 4 | 0.030 |
Why?
| Adrenergic Uptake Inhibitors | 1 | 2015 | 14 | 0.030 |
Why?
| Attention | 1 | 2019 | 443 | 0.030 |
Why?
| Self Report | 1 | 2020 | 730 | 0.030 |
Why?
| Diffusion Tensor Imaging | 1 | 2016 | 85 | 0.030 |
Why?
| Organ Size | 1 | 2016 | 474 | 0.030 |
Why?
| Thymus Gland | 1 | 2016 | 308 | 0.030 |
Why?
| Genomics | 1 | 2020 | 714 | 0.030 |
Why?
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2014 | 6 | 0.030 |
Why?
| Freezing Reaction, Cataleptic | 1 | 2014 | 23 | 0.030 |
Why?
| Rabbits | 1 | 2016 | 808 | 0.030 |
Why?
| Mifepristone | 1 | 2014 | 66 | 0.030 |
Why?
| Environment | 1 | 2017 | 357 | 0.030 |
Why?
| Executive Function | 1 | 2019 | 406 | 0.030 |
Why?
| Mice, Inbred ICR | 1 | 2014 | 111 | 0.030 |
Why?
| Glutamic Acid | 1 | 2016 | 227 | 0.030 |
Why?
| Enzyme Inhibitors | 1 | 2018 | 836 | 0.030 |
Why?
| Inflammatory Bowel Diseases | 1 | 2018 | 290 | 0.030 |
Why?
| Calcium | 1 | 2000 | 1244 | 0.030 |
Why?
| Electrochemical Techniques | 1 | 2014 | 40 | 0.030 |
Why?
| Immune System Diseases | 1 | 2014 | 36 | 0.030 |
Why?
| Catalysis | 1 | 2014 | 295 | 0.030 |
Why?
| Colorado | 1 | 2024 | 4325 | 0.030 |
Why?
| Self-Injurious Behavior | 1 | 2015 | 126 | 0.030 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2016 | 513 | 0.030 |
Why?
| Receptors, Opioid, kappa | 2 | 1990 | 11 | 0.030 |
Why?
| Memory Disorders | 1 | 2014 | 170 | 0.030 |
Why?
| Heterozygote | 1 | 2014 | 270 | 0.030 |
Why?
| Angiotensin II Type 2 Receptor Blockers | 1 | 2013 | 8 | 0.030 |
Why?
| Mothers | 1 | 1999 | 728 | 0.030 |
Why?
| Cues | 1 | 2015 | 310 | 0.030 |
Why?
| Angiotensin II Type 1 Receptor Blockers | 1 | 2013 | 35 | 0.030 |
Why?
| Adaptation, Physiological | 2 | 2009 | 510 | 0.030 |
Why?
| Pandemics | 1 | 2021 | 1401 | 0.030 |
Why?
| Naloxone | 2 | 1990 | 88 | 0.030 |
Why?
| Genome-Wide Association Study | 1 | 2019 | 1376 | 0.030 |
Why?
| Odds Ratio | 1 | 2015 | 1043 | 0.030 |
Why?
| Orexins | 1 | 2012 | 5 | 0.030 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2020 | 2127 | 0.030 |
Why?
| Naphthyridines | 1 | 2012 | 16 | 0.030 |
Why?
| Benzoxazoles | 1 | 2012 | 17 | 0.030 |
Why?
| Androgens | 1 | 1994 | 169 | 0.030 |
Why?
| Sex Factors | 1 | 2018 | 1860 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2019 | 2599 | 0.030 |
Why?
| Urea | 1 | 2012 | 78 | 0.030 |
Why?
| Imidazoles | 1 | 2013 | 234 | 0.030 |
Why?
| Respiration | 1 | 2012 | 189 | 0.020 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 346 | 0.020 |
Why?
| Muscle Strength | 1 | 2014 | 290 | 0.020 |
Why?
| Fetal Development | 1 | 2014 | 263 | 0.020 |
Why?
| Specific Pathogen-Free Organisms | 1 | 2010 | 65 | 0.020 |
Why?
| Estrogens | 1 | 1994 | 325 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2018 | 2977 | 0.020 |
Why?
| Morphinans | 1 | 1989 | 7 | 0.020 |
Why?
| Receptors, Opioid, mu | 1 | 1990 | 52 | 0.020 |
Why?
| Organic Chemicals | 1 | 2010 | 132 | 0.020 |
Why?
| Morphine | 1 | 1990 | 137 | 0.020 |
Why?
| Heart Rate | 1 | 2013 | 756 | 0.020 |
Why?
| Mass Screening | 1 | 2016 | 1095 | 0.020 |
Why?
| Allylglycine | 1 | 2007 | 2 | 0.020 |
Why?
| Choline O-Acetyltransferase | 1 | 2007 | 21 | 0.020 |
Why?
| Phosphopyruvate Hydratase | 1 | 2007 | 35 | 0.020 |
Why?
| Electric Stimulation | 1 | 2008 | 273 | 0.020 |
Why?
| Child | 2 | 2019 | 19561 | 0.020 |
Why?
| Glutamate Decarboxylase | 1 | 2007 | 160 | 0.020 |
Why?
| Autonomic Nervous System | 1 | 2007 | 67 | 0.020 |
Why?
| Pyrroles | 1 | 2008 | 199 | 0.020 |
Why?
| Pain | 1 | 2013 | 746 | 0.020 |
Why?
| 1-Methyl-4-phenylpyridinium | 1 | 2006 | 5 | 0.020 |
Why?
| Cells, Cultured | 1 | 2014 | 4162 | 0.020 |
Why?
| Cimetidine | 1 | 1986 | 16 | 0.020 |
Why?
| Ranitidine | 1 | 1986 | 13 | 0.020 |
Why?
| Neural Inhibition | 1 | 2007 | 165 | 0.020 |
Why?
| Obesity | 1 | 2019 | 2786 | 0.020 |
Why?
| Growth Hormone | 1 | 1986 | 109 | 0.020 |
Why?
| Testis | 1 | 1986 | 145 | 0.020 |
Why?
| Pyrimidines | 1 | 2008 | 388 | 0.020 |
Why?
| Statistics, Nonparametric | 1 | 2005 | 416 | 0.020 |
Why?
| Inspiratory Capacity | 1 | 2004 | 2 | 0.020 |
Why?
| Single-Blind Method | 1 | 2004 | 275 | 0.010 |
Why?
| Mutation | 1 | 2014 | 3493 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 2012 | 2359 | 0.010 |
Why?
| Reference Values | 1 | 2004 | 789 | 0.010 |
Why?
| Treatment Outcome | 1 | 2016 | 9692 | 0.010 |
Why?
| Periodicity | 1 | 2000 | 56 | 0.010 |
Why?
| Retrospective Studies | 1 | 2017 | 13433 | 0.010 |
Why?
| Pyramidal Cells | 1 | 1999 | 54 | 0.010 |
Why?
| Atrophy | 1 | 1999 | 167 | 0.010 |
Why?
| Progesterone | 1 | 1999 | 243 | 0.010 |
Why?
| RNA, Complementary | 1 | 1997 | 3 | 0.010 |
Why?
| Sulfur Radioisotopes | 1 | 1997 | 17 | 0.010 |
Why?
| Thyrotropin-Releasing Hormone | 1 | 1997 | 13 | 0.010 |
Why?
| Oligonucleotide Probes | 1 | 1997 | 54 | 0.010 |
Why?
| Neuronal Plasticity | 1 | 1999 | 224 | 0.010 |
Why?
| Estradiol | 1 | 1999 | 477 | 0.010 |
Why?
| Body Mass Index | 1 | 2000 | 2144 | 0.010 |
Why?
| Testosterone | 1 | 1994 | 353 | 0.010 |
Why?
| Surveys and Questionnaires | 1 | 2000 | 4882 | 0.010 |
Why?
| Dyspepsia | 1 | 1986 | 9 | 0.000 |
Why?
| Gonadal Steroid Hormones | 1 | 1986 | 123 | 0.000 |
Why?
| Glucose Tolerance Test | 1 | 1986 | 370 | 0.000 |
Why?
| Insulin | 1 | 1986 | 2180 | 0.000 |
Why?
|
|
Lowry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|